Patients are arriving at your OPD clutching Instagram reels about their "gut health." Some are spending ₹5,000 a month on probiotic supplements. Others have had expensive stool microbiome sequencing done. As a clinician, you need to know what the science actually says — and how to separate signal from noise. What Is the Gut Microbiome? The human gut contains approximately 38 trillion microorganisms — bacteria, viruses, fungi, and archaea — collectively called the microbiome. These organisms perform crucial functions: digesting complex carbohydrates, producing short-chain fatty acids (SCFAs), synthesising vitamins (B12, K2, folate), modulating immune responses, and communicating with the brain via the gut-brain axis. Disruption of the microbiome — called dysbiosis — is associated with a range of conditions including obesity, type 2 diabetes, inflammatory bowel disease, MASLD, mental health disorders, and autoimmune conditions. What the Evidence Shows in Indian Populations Indian microbiome research is at an early but accelerating stage. Key findings: Indian gut microbiome composition differs significantly from Western populations, reflecting differences in diet (higher fibre, more fermented foods in traditional diets) and genetics Urban Indian populations have lower microbiome diversity compared to rural populations — a pattern associated with higher NCD rates High consumption of ultra-processed foods, commonly seen in urban middle-class India, is associated with reduced Firmicutes/Bacteroidetes ratios and reduced SCFA production The South Asian "thin-fat" phenotype (normal BMI, high visceral fat, early insulin resistance) may be partly mediated by microbiome differences The Gut-Metabolic Disease Connection Type 2 Diabetes: Dysbiosis reduces SCFA production (particularly butyrate), which impairs intestinal barrier function, increases inflammatory endotoxin (lipopolysaccharide) entry into circulation, and drives systemic low-grade inflammation — a key driver of insulin resistance. Conversely, metformin — India's most prescribed antidiabetic — works partly through microbiome modulation, increasing Akkermansia muciniphila populations, which are associated with better glycaemic control and intestinal health. Obesity: Microbiome transplant studies have shown that gut bacteria from obese donors can transfer an obese phenotype to germ-free mice. Specific bacterial genera — reduced Akkermansia and Bifidobacterium, increased Firmicutes — are consistently found in obese individuals. Mental Health: The gut-brain axis is real. Approximately 90% of the body's serotonin is produced in the gut. Dysbiosis is associated with anxiety, depression, and cognitive dysfunction. This is relevant in India given the high burden of unrecognised mental health conditions in primary care. Clinician Takeaways on the Gut Microbiome (Indian Context) 1. What the Gut Microbiome Is ~38 trillion organisms (bacteria, viruses, fungi, archaea) in the gut Key roles: complex carb digestion, SCFA production (especially butyrate), vitamin synthesis (B12, K2, folate), immune modulation, gut–brain signalling Dysbiosis is associated (not always causally proven) with: obesity, type 2 diabetes, IBD, MASLD, mental health disorders, autoimmune disease 2. Indian-Specific Evidence Indian gut microbiome ≠ Western microbiome: driven by traditional high-fibre, fermented, plant-rich diets and genetic background Urban India: lower diversity vs rural; correlates with higher NCD burden Ultra-processed foods → reduced diversity, altered Firmicutes/Bacteroidetes balance, lower SCFAs South Asian “thin-fat” phenotype may be partly microbiome-mediated (visceral adiposity, early insulin resistance despite normal BMI) 3. Links to Metabolic & Other Diseases Type 2 Diabetes Dysbiosis → ↓ butyrate → impaired gut barrier → ↑ LPS translocation → chronic low-grade inflammation → insulin resistance Metformin partly acts via microbiome: ↑ Akkermansia muciniphila → better barrier integrity and glycaemic control Obesity Fecal microbiota from obese donors can transmit obesity phenotype to germ-free mice Obesity pattern: ↓ Akkermansia, ↓ Bifidobacterium, often ↑ Firmicutes/Bacteroidetes ratio